UT Research Park Partner Arkis Biosciences Acquired

The good news for technology-based companies in the Knoxville-Oak Ridge region just keeps getting better and better with another acquisition of a local start-up.

Integra LifeSciences Holdings Corporation, a leading global medical technology company based in New Jersey, announced yesterday that it has acquired Arkis Biosciences Inc., a privately-held company that offers a portfolio of neurosurgical devices. Among them is the CerebroFlo® external ventricular drainage (EVD) catheter with Endexo® technology, a permanent additive designed to reduce the potential for catheter obstruction due to thrombus formation.

The acquisition of Arkis Biosciences, which is located in the privately-developed building on the University of Tennessee Research Park, strengthens Integra’s offerings in neurocritical care and Integra’s position as the world leader in advanced catheter technology.

Continue reading at teknovation.biz.


The acquisition was also announced at Verdict Media, an industry publication site specializing in medical device technology.